Related references
Note: Only part of the references are listed.Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI)
Mike A. Nalls et al.
MOVEMENT DISORDERS (2016)
NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
Mike A. Nalls et al.
NEUROBIOLOGY OF AGING (2015)
Neuroimaging Biomarkers for Parkinson Disease: Facts and Fantasy
Joel S. Perlmutter et al.
ANNALS OF NEUROLOGY (2014)
Low clinical diagnostic accuracy of early vs advanced Parkinson disease Clinicopathologic study
Charles H. Adler et al.
NEUROLOGY (2014)
Salivary DJ-1 could be an indicator of Parkinson's disease progression
Wen-Yan Kang et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Genetics and genomics of Parkinson's disease
Michelle K. Lin et al.
GENOME MEDICINE (2014)
Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation
Er-Song Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
LRRK2 secretion in exosomes is regulated by 14-3-3
Kyle B. Fraser et al.
HUMAN MOLECULAR GENETICS (2013)
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
Glenn T. Stebbins et al.
MOVEMENT DISORDERS (2013)
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
Penelope G. Foulds et al.
SCIENTIFIC REPORTS (2013)
Activity enhances dopaminergic long-duration response in Parkinson disease
U. Jung Kang et al.
NEUROLOGY (2012)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
Ivana Devic et al.
BRAIN (2011)
Identification of blood microRNAs associated to Parkinsonis disease
Regina Margis et al.
JOURNAL OF BIOTECHNOLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Medication Responsiveness of Motor Symptoms in a Population-Based Study of Parkinson Disease
Yvette M. Bordelon et al.
PARKINSONS DISEASE (2011)
The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
Lisa M. Shulman et al.
ARCHIVES OF NEUROLOGY (2010)
Frequency of Known Mutations in Early-Onset Parkinson Disease
Roy N. Alcalay et al.
ARCHIVES OF NEUROLOGY (2010)
Mild cognitive impairment in Parkinson disease A multicenter pooled analysis
D. Aarsland et al.
NEUROLOGY (2010)
2009 Biospecimen Research Network Symposium: Advancing Cancer Research through Biospecimen Science
H. M. Moore et al.
CANCER RESEARCH (2009)
Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients
Yoshiro Saito et al.
NEUROSCIENCE LETTERS (2009)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
The REM sleep behavior disorder screening questionnaire -: A new diagnostic instrument
Karin Stiasny-Kolster et al.
MOVEMENT DISORDERS (2007)
Role of DAT-SPECT in the diagnostic work up of Parkinsonism
Christoph Scherfler et al.
MOVEMENT DISORDERS (2007)
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
DR Williams et al.
BRAIN (2005)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Weight loss in Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2003)
Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis
M Merello et al.
MOVEMENT DISORDERS (2002)
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
AJ Hughes et al.
BRAIN (2002)
The heterogeneity of idiopathic Parkinson's disease
T Foltynie et al.
JOURNAL OF NEUROLOGY (2002)
Stroke and apolipoprotein E ε4 are independent risk factors for cognitive decline -: A population-based study
MG Dik et al.
STROKE (2000)
Share Paper
